Tarsus Pharmaceuticals In... (TARS)
NASDAQ: TARS
· Real-Time Price · USD
55.39
0.13 (0.24%)
At close: Sep 25, 2025, 3:59 PM
55.39
0.00%
After-hours: Sep 25, 2025, 04:18 PM EDT
0.24% (1D)
Bid | 54 |
Market Cap | 2.34B |
Revenue (ttm) | 295.52M |
Net Income (ttm) | -91.99M |
EPS (ttm) | -2.29 |
PE Ratio (ttm) | -24.19 |
Forward PE | 57.35 |
Analyst | Buy |
Dividends | n/a |
Ask | 59 |
Volume | 358,998 |
Avg. Volume (20D) | 671,900 |
Open | 55.17 |
Previous Close | 55.26 |
Day's Range | 54.16 - 56.25 |
52-Week Range | 31.36 - 59.76 |
Beta | 0.82 |
Ex-Dividend Date | n/a |
About TARS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TARS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TARS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsTarsus Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-5.84%
Tarsus Pharmaceuticals shares are trading lower fo...
Unlock content with
Pro Subscription
7 months ago
-9.33%
Shares of Tarsus Pharmaceuticals are trading lower. The company reported Q4 financial results.

1 month ago · seekingalpha.com
Tarsus Pharmaceuticals, Inc. (TARS) Q2 2025 Earnings Call TranscriptTarsus Pharmaceuticals, Inc. (NASDAQ:TARS ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Aziz Mottiwala - Chief Commercial Officer Bobak R. Azamian - Co-Founder, Pre...